Skip to content

Diabetes Self-Management Education

Effectiveness of a nurse-led diabetes self-management education on glycosylated hemoglobin in Iranian Kurdish adults with type 2 diabetes

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016062528627N1
Enrollment
142
Registered
2016-09-24
Start date
2016-11-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Diabetes mellitus

Interventions

Intervention 1: Intervention Group: Receiving the diabetes self-management booklet: The content of “diabetes self-care booklet” provided by Paul Tracy “learning about diabetes” (Tracy, 2015) and Ameri
Behavior
Intervention Group: Receiving the diabetes self-management booklet: The content of “diabetes self-care booklet” provided by Paul Tracy “learning about diabetes” (Tracy, 2015) and American Diabetes A
Intervention Group: Viewing four 10-min movie episodes: During the first 4 weeks of the intervention, participants will be invited to watch four 10-min movie weekly episodes with instructions to rem
Intervention Group: Participating in four weekly group sessions: Four group sessions at weekly interval will be undertaken. The goal of group session is to help patients acquire the information, kn
Intervention Group: Participating in Telephone Follow-up: During the two months following the end of the focus group sessions, the researcher provided one call per week to participants in the exper
Control Group: Usual diabetes care will be provided for all patients regardless of group allocation. The usual diabetes care practice is based on the Iranian Ministry of Health Guideline on the manag

Sponsors

Vice chancellor for research, Medical University of Ilam, Iran
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Major inclusion criteria: Being Iranian people; Aged 18 years and above; Being clinically diagnosed with T2DM at least for 6 months; Have medical record showing HbA1c = 8%; Being independent in activity of daily living; Having the ability to read and write the Persian; Have a telephone in their residence and be able to use it effectively; Participating in regular follow-up; at least two visits in the last year ; No acute medical illness in the last 6 months;. Major exclusion criteria: Have T2DM combined with severe complications which would interfere with self-care such as blindness, being on dialysis, DKA, and the severe stroke; Have the medical history of cognitive deficits such as dementia; Have uncontrolled hypertension (blood pressure = 180/110 mmHg); Known hearing impairment; Known vision impairment; Unable to participate in the education program (for example are housebound or unable to communicate in Persian or Kurdish or are participating in another research study); Have hemolytic anemias, hemoglobinopathies;

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Glycosylated Hemoglobin (HbA1c). Timepoint: Baseline, 3 months, 6 months. Method of measurement: Laboratory Measure.

Secondary

MeasureTime frame
Lipid profiles (TG, Cholesterol,HDl, LDL. Timepoint: Baseline, 3 months, 6 months. Method of measurement: Laboratory Measures.;Blood Pressure. Timepoint: Baseline, 3 months, 6 months. Method of measurement: Clinical Measure.;Body Mass Index (BMI). Timepoint: Baseline, 3 months, 6 months. Method of measurement: Clinical Measure.;Diabetes Self-Management Behavior. Timepoint: Baseline, 3 months, 6 months. Method of measurement: Diabetes Self-Management Questionnaire (DSMQ).;Self-efficacy. Timepoint: Baseline, 3 months, 6 months. Method of measurement: Diabetes Management Self-Efficacy Scale (DMSES).;Quality of life. Timepoint: Baseline, 3 months, 6 months. Method of measurement: World Health Organization Quality of Life Scale (WHOQOL-BREF).;Depression. Timepoint: Baseline, 3 months, 6 months. Method of measurement: The Center for Epidemiology Studies Short Depression Scale (CES-D).;Social Support. Timepoint: Baseline, 3 months, 6 months. Method of measurement: Medical Outcome Study (MOS) Social Support Survey (SSS) tool.;Outcome Expectation. Timepoint: Baseline, 3 months, 6 months. Method of measurement: The Perceived Therapeutic Efficacy Scale (PTES).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGolnaz Azami

Ilam Medical University, 6939177143, Pajohesh Blvd, Bangangab, Ilam, Iran

golnaz.azami64@gmail.com+98 84 3333 6766

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 23, 2026